Madrigal Mental Care is focused on using nanotechnology to accurately deliver psychedelic drugs for the treatment of mental health conditions such as post-traumatic stress disorder (PTSD).

The company's Nanovo intranasal spray is designed to deliver active, nanoencapsulated psychedelic substances directly to the brain for rapid, safe, and efficient uptake.

Madrigal utilizes molecules composed of psychedelic drugs such as psilocybin, ketamine, mescaline, MDMA, and more. By fundamentally changing the coding in the brain, rather than simply treating symptoms, the company is able to offer a transformative solution with minimal side effects.